438 related items for PubMed ID: 8310664
1. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[Abstract] [Full Text] [Related]
2. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL, Shkerina LI, Shilov EM.
Klin Med (Mosk); 2005 Dec; 83(10):48-50. PubMed ID: 16320847
[Abstract] [Full Text] [Related]
3. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[Abstract] [Full Text] [Related]
4. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
Klinger M, Szewczyk Z.
Przegl Lek; 1989 Oct; 46(12):816-21. PubMed ID: 2698488
[No Abstract] [Full Text] [Related]
5. [Present possibilities of treatment of primary chronic glomerulonephritis].
Knotková V, Nĕmecek K.
Vnitr Lek; 1994 Jun; 40(6):345-8. PubMed ID: 8073642
[Abstract] [Full Text] [Related]
6. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
Riabov SI, Stavskaia VV, Sheveleva LA.
Ter Arkh; 1990 Jun; 62(9):91-7. PubMed ID: 2281418
[Abstract] [Full Text] [Related]
7. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
8. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa, Biriukova LS, Makurov AI.
Ter Arkh; 1992 Nov; 64(8):47-50. PubMed ID: 1440396
[No Abstract] [Full Text] [Related]
9. The therapy of idiopathic membranous glomerulonephritis.
Glassock RJ.
Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
[Abstract] [Full Text] [Related]
10. Nephrotic syndrome in the elderly. A retrospective study in steroid-treated patients.
Palmieri PF, Bonomini M, Di Mizio G, Manfrini V, Summa R, Stuard S, Albertazzi A.
Contrib Nephrol; 1993 Mar; 105():58-64. PubMed ID: 8252872
[No Abstract] [Full Text] [Related]
11. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
12. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
Krasnova TN, Shilov EM, Ivanov AA, Samoĭlov DV, Gordovskaia NB, Miroshnichenko NG, Tareeva IE.
Ter Arkh; 1991 Aug; 63(6):115-8. PubMed ID: 1948725
[Abstract] [Full Text] [Related]
13. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
14. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[Abstract] [Full Text] [Related]
15. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
Ter Arkh; 1998 May; 70(6):14-7. PubMed ID: 9695216
[Abstract] [Full Text] [Related]
16. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
Jindal K, West M, Bear R, Goldstein M.
Am J Kidney Dis; 1992 Jan; 19(1):61-7. PubMed ID: 1739084
[Abstract] [Full Text] [Related]
17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P, Frey FJ.
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[Abstract] [Full Text] [Related]
18. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
[Abstract] [Full Text] [Related]
19. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Fujimoto S, Yamamoto Y, Wakisaka O, Hisanaga S, Miyata J, Tanaka K.
Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
[No Abstract] [Full Text] [Related]
20. [The late results of treating membranous glomerulonephritis].
Belovezhdov N, Robeva R, Dimitrova V.
Vutr Boles; 1990 Jun; 29(3):53-60. PubMed ID: 2284800
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
